Barclays Maintains Overweight on Sempra, Raises Price Target to $89
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Eric Beaumont maintains an Overweight rating on Sempra (NYSE:SRE) and raises the price target from $87 to $89.
October 01, 2024 | 3:54 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays analyst Eric Beaumont has maintained an Overweight rating on Sempra and increased the price target from $87 to $89, indicating a positive outlook.
The increase in price target from $87 to $89 by Barclays suggests a positive outlook for Sempra's stock. The Overweight rating indicates that the analyst expects the stock to outperform the average total return of stocks in the analyst's coverage universe. This is likely to have a positive short-term impact on Sempra's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100